{"product_id":"plcgamma1-antibody-sc-f0705","title":"Phospho-PLCγ1 (Ser1248) Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003ePLCGAMMA1 is a target of interest in many antibody-based workflows. Phosphoinositide-specific phospholipase C (PLC) is a crucial player in transmembrane signaling pathways. Upon stimulation by extracellular signals like hormones, growth factors, and neurotransmitters, PLC catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into two important secondary messengers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). Four families of PLCs have been identified, namely PLCβ, PLCγ, PLCδ, and PLCε. Depending on the literature source, PLCGAMMA1 may also be discussed as Phospho-PLCgamma1 (Ser1248).\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell projection, which can matter when signal is compared across treatments or changing cell states. Following PLCGAMMA1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003ePLCGAMMA1 is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell projection, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003esignal enrichment within cell projection relative to the broader cellular background\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003edifferences between total target abundance and site-specific regulation when modified forms are compared\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for PLCGAMMA1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in PLCGAMMA1 reflect biology rather than handling. When interpreting PLCGAMMA1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep PLCGAMMA1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577505259865,"sku":"F0705-20UL","price":169.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577505292633,"sku":"F0705-100UL","price":389.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577505325401,"sku":"F0705-2X100UL","price":579.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0705-IF.png?v=1773598818","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/plcgamma1-antibody-sc-f0705","provider":"Absource Diagnostics","version":"1.0","type":"link"}